These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2706131)

  • 41. Nuclear DNA content and prognosis in human breast cancer: a static cytophotometric study.
    Harvey J; de Klerk N; Berryman I; Sterrett G; Byrne M; Papadimitriou J
    Breast Cancer Res Treat; 1987; 9(2):101-9. PubMed ID: 3304476
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Predictive factors for sentinel node metastases in primary invasive breast cancer: a population-based cohort study of 2552 consecutive patients.
    Majid S; Rydén L; Manjer J
    World J Surg Oncol; 2018 Mar; 16(1):54. PubMed ID: 29530065
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Coexistence of cytoplasmic and nuclear estrogen receptors. A histochemical study on human mammary cancer and rabbit uterus.
    Lee SH
    Cancer; 1989 Oct; 64(7):1461-6. PubMed ID: 2550122
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Analysis of interval breast carcinomas in a randomized screening trial in Stockholm.
    Frisell J; Eklund G; Hellström L; Somell A
    Breast Cancer Res Treat; 1987; 9(3):219-25. PubMed ID: 3663958
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Receptors for estrogen and progesterone in breast carcinoma in situ.
    Pallis L; Wilking N; Cedermark B; Rutqvist LE; Skoog L
    Anticancer Res; 1992; 12(6B):2113-5. PubMed ID: 1295456
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.
    Glass AG; Lacey JV; Carreon JD; Hoover RN
    J Natl Cancer Inst; 2007 Aug; 99(15):1152-61. PubMed ID: 17652280
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nonpalpable invasive breast cancer.
    Wilhelm MC; Edge SB; Cole DD; deParedes E; Frierson HF
    Ann Surg; 1991 Jun; 213(6):600-3; discussion 603-5. PubMed ID: 2039291
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Primary breast cancer. Flow cytometric DNA pattern in relation to clinical and histopathologic characteristics.
    Thorud E; Fosså SD; Vaage S; Kaalhus O; Knudsen OS; Børmer O; Shoaib MC
    Cancer; 1986 Feb; 57(4):808-11. PubMed ID: 3943014
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Correlation of estrogen and progesterone receptors with histologic differentiation in mammary carcinoma.
    McCarty KS; Barton TK; Fetter BF; Woodard BH; Mossler JA; Reeves W; Daly J; Wilkinson WE; McCarty KS
    Cancer; 1980 Dec; 46(12 Suppl):2851-8. PubMed ID: 6256054
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Receptors for EGF and oestradiol and thymidinekinase activity in different histological subgroups of human mammary carcinomas.
    Skoog L; Macias A; Azavedo E; Lombardero J; Klintenberg C
    Br J Cancer; 1986 Aug; 54(2):271-6. PubMed ID: 3017397
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The relationship of steroid receptor expression to nuclear DNA distribution and clinicopathological characteristics in epithelial ovarian tumors.
    Friedlander ML; Quinn MA; Fortune D; Foo MS; Toppila M; Hudson CN; Russell P
    Gynecol Oncol; 1989 Feb; 32(2):184-90. PubMed ID: 2910780
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The significance of quantitative biological cell parameters in the handling of mammary carcinoma.
    Theve NO; Azavedo E; Blomstedt B; Wiking N; Auer GU
    Acta Chir Scand; 1982; 148(3):239-41. PubMed ID: 6291293
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Utility of Sox10 labeling in metastatic breast carcinomas.
    Nelson ER; Sharma R; Argani P; Cimino-Mathews A
    Hum Pathol; 2017 Sep; 67():205-210. PubMed ID: 28843711
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic value of DNA cytometry in 281 premenopausal patients with lymph node negative breast carcinoma randomized in a control trial: multivariate analysis with Ki-67 index, mitotic count, and microvessel density.
    Mandard AM; Denoux Y; Herlin P; Duigou F; van De Vijver MJ; Clahsen PC; van Den Broek L; Sahmoud TM; Henry-Amar M; van De Velde CJ
    Cancer; 2000 Oct; 89(8):1748-57. PubMed ID: 11042570
    [TBL] [Abstract][Full Text] [Related]  

  • 55. DNA ploidy is an independent predictor of survival in breast invasive ductal carcinoma: a long-term multivariate analysis of 393 patients.
    Pinto AE; Pereira T; Santos M; Branco M; Dias A; Silva GL; Ferreira MC; André S
    Ann Surg Oncol; 2013 May; 20(5):1530-7. PubMed ID: 23250736
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oestrogen receptor expression in ductal carcinoma in situ of the breast: relationship to flow cytometric analysis of DNA and expression of the c-erbB-2 oncoprotein.
    Poller DN; Snead DR; Roberts EC; Galea M; Bell JA; Gilmour A; Elston CW; Blamey RW; Ellis IO
    Br J Cancer; 1993 Jul; 68(1):156-61. PubMed ID: 8100443
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Assay of DNA content and estrogen receptor status in human breast cancer].
    Chen GJ; Shao YF; Shan Y
    Zhonghua Zhong Liu Za Zhi; 1994 Nov; 16(6):461-4. PubMed ID: 7720507
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Detection of estrogen receptor by immunohistochemistry in pulmonary adenocarcinoma.
    Dabbs DJ; Landreneau RJ; Liu Y; Raab SS; Maley RH; Tung MY; Silverman JF
    Ann Thorac Surg; 2002 Feb; 73(2):403-5; discussion 406. PubMed ID: 11845849
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison between histologic type, estrogen receptor, and nuclear DNA content in mammary carcinoma.
    Erhardt K; Auer G; Folin A; Silfverswärd C; Skoog L
    Am J Clin Oncol; 1986 Feb; 9(1):83-9. PubMed ID: 3006475
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinicopathologic features of breast cancers that develop in women with previous benign breast disease.
    Visscher DW; Frost MH; Hartmann LC; Frank RD; Vierkant RA; McCullough AE; Winham SJ; Vachon CM; Ghosh K; Brandt KR; Farrell AM; Tarabishy Y; Hieken TJ; Haddad TC; Kraft RA; Radisky DC; Degnim AC
    Cancer; 2016 Feb; 122(3):378-85. PubMed ID: 26512815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.